| |
| |
|
| Insider
Information: |
Haughey Thomas |
| Relationship: |
Director |
| City: |
Woodcliff Lake |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
51,526 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,465,124 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
51,526 |
|
|
| Total
Value |
$3,465,124 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
President, Director |
2012-09-28 |
0 |
2012-09-28 |
0 |
Premium* |
|
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2024-05-21 |
51,526 |
2018-06-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-09 |
4 |
S |
$34.45 |
$3,720,200 |
D/D |
(106,493) |
79,055 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• • – |
2012-09-28 |
4 |
D |
$50.00 |
$3,482,400 |
D/D |
(69,648) |
0 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-09 |
4 |
OE |
$10.99 |
$753,815 |
D/D |
68,591 |
185,648 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Coun |
• – – |
2008-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
45,496 |
177,808 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Exec VP, General Counsel |
• – – |
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
36,849 |
132,811 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Exec VP, General Counsel |
• – – |
2008-01-11 |
4/A |
A |
$0.00 |
$0 |
D/D |
36,849 |
133,171 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, Gen Counsel |
• – – |
2010-03-01 |
4 |
S |
$25.08 |
$786,545 |
D/D |
(31,301) |
139,480 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
officerTitle |
• – – |
2006-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
30,066 |
47,617 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Exec VP, Gen Counsel & Secy |
• – – |
2007-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
28,200 |
75,817 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-10 |
4 |
OE |
$13.06 |
$350,008 |
D/D |
26,800 |
105,855 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-10 |
4 |
S |
$35.45 |
$952,727 |
D/D |
(26,800) |
79,055 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, Gen Counsel |
• – – |
2010-03-01 |
4 |
OE |
$13.06 |
$349,995 |
D/D |
26,799 |
170,781 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Exec VP, General Counsel, Secy |
• – – |
2006-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
24,300 |
24,300 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
21,603 |
139,962 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-11 |
4 |
D |
$35.98 |
$714,743 |
D/D |
(19,865) |
120,097 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Vice Pres, Gen Counsel, Secy |
• – – |
2005-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,551 |
17,551 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2010-11-18 |
4 |
D |
$37.72 |
$497,112 |
D/D |
(13,179) |
113,186 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Chief Admin Off, Gen Coun |
• – – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,631 |
147,514 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, Gen Counsel |
• – – |
2010-03-02 |
4 |
S |
$25.45 |
$273,834 |
D/D |
(10,756) |
128,724 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
|
– • – |
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,049 |
40,251 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
|
– • – |
2021-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,292 |
27,702 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
8,894 |
118,383 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,870 |
118,359 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2020-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,119 |
18,410 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,865 |
47,116 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
